Clinical Trial Update: Safety of NovoMix® 30 or Levemir® for Treatment of Type 2 Diabetics in Macedonia

View source ↗

Summary

This entry documents the completion of a clinical trial evaluating the safety of NovoMix 30 and Levemir in adults with Type 2 diabetes in Macedonia. The trial w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Levemir (insulin detemir)
• NovoMix 30 (insulin aspart protamine fixed-dose combination)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Status: COMPLETED